PATENT CLAIM ANALYSIS

Application Number: 15956124
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "635000"]

Abstract:
The invention relates to a method of treating or preventing a condition in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof. The invention further relates to a method of improving a physiological function in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof.

Claim (Index 15):
The method of  claim 8 , wherein the meglumine salt is formed between meglumine and an acid selected from the group consisting of sulfate, hydrogen sulfate, hydrochloric, hydrobromic, hydriodic, nitric, carbonic, sulfuric, phosphoric, formic, acetic, propionic, succinic, glycolic, gluconic, lactic, malic, tartaric, citric, ascorbic, glucuronic, maleic, fumaric, pyruvic, aspartic, glutamic, benzoic, anthranilic, 4-hydroxybenzoic, phenylacetic, mandelic, embonic, methanesulfonic, ethanesulfonic, benzenesulfonic, pantothenic, trifluoromethanesulfonic, 2-hydroxyethanesulfonic, p-toluenesulfonic, sulfanilic, cyclohexylaminosulfonic, stearic, alginic, \u03b2-hydroxybutyric, salicylic, galactaric, and galacturonic acid.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 2.21429
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15413455', '13962645', '14673259', '10198706', '11818997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8056508248164832
- 35 USC 102 Novelty (BERT): 0.5234967348346057
- Combined Prediction Score: 0.7774354158182954
- Mean Citation Score: 256.46477400000003
- Max Citation Score: 310.92578
- Similarity Product: 188.71085626202583

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test